本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Galmed Pharmaceuticals Ltd.

1.21
-0.0707-5.52%
成交量:17.52万
成交额:21.94万
市值:273.06万
市盈率:-0.15
高:1.30
开:1.30
低:1.20
收:1.28
数据加载中...
2023/06/28

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/06/17

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/03/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/18

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/18

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals